Skip to main content
SpringerLink
Log in

Pharmacokinetics as an Aid to Optimising Compliance with Medications

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rudd P, Ahmed S, Zachary V, et al. Improved compliance measures: applications in an ambulatory hypertensive drug trial. Clin Pharmacol Ther 1990; 48(12): 676–85

    Article  PubMed  CAS  Google Scholar 

  2. Rudd P. Maximizing compliance with antihypertensive therapy. Drug Ther 1992; 22(12): 25–32

    Google Scholar 

  3. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991; 48(9): 1978–88

    PubMed  CAS  Google Scholar 

  4. Sackett DL. Methods for compliance research. In: Haynes RB, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: John Hopkins, 1979: 323–33

    Google Scholar 

  5. Dunbar J. Adherence measures and their utility. Control Clin Trials 1984; 5: 515–21

    Article  PubMed  CAS  Google Scholar 

  6. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24(1): 67–74

    Article  PubMed  CAS  Google Scholar 

  7. Stewart M. The validity of an interview to assess a patient’s drug taking. Am J Prev Med 1987; 3(2): 95–100

    PubMed  CAS  Google Scholar 

  8. Hasford J. Biometric issues in measuring and analyzing partial compliance in clinical trials. In: Cramer JA, Spilker B, editors. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991: 265–81

    Google Scholar 

  9. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987; 2: 23–35

    Google Scholar 

  10. Rudd P, Ramesh J, Bryant-Kosling C, et al. Gaps in cardiovascular medication taking: the tip of the iceberg. J Gen Intern Med 1993; 8: 659–66

    Article  PubMed  CAS  Google Scholar 

  11. Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacological indicator to compare compliance with tablets prescribed once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540–5

    Article  PubMed  CAS  Google Scholar 

  12. Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 163–8

    Article  PubMed  CAS  Google Scholar 

  13. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150(7): 1509–10

    Article  PubMed  CAS  Google Scholar 

  14. Gatley MS. To be taken as directed. J R Coll Gen Pract 1968; 16: 39–44

    PubMed  CAS  Google Scholar 

  15. Porter AMW. Drug defaulting in a general practice. BMJ 1969; 1: 218–22

    Article  PubMed  CAS  Google Scholar 

  16. Parkin DM, Henney CR, Quirk J, et al. Deviation from prescribed drug treatment after discharge from hospital. BMJ 1976; 2: 686–8

    Article  PubMed  CAS  Google Scholar 

  17. Wiseman IC, Miller R. Quantifying non-compliance in patients receiving digoxin — a pharmacokinetic approach [published erratum appears in S Afr Med J 1991 Mar 2; 79(5): 286]. S Afr Med J 1991; 79(3): 155–7

    PubMed  CAS  Google Scholar 

  18. Taggart AJ, Johnston GD, McDevitt DG. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1981; 1: 31–4

    Article  Google Scholar 

  19. Levy G. A pharmacokinetic perspective on medicament noncompliance. Clin Pharmacol Ther 1993; 54: 242–4

    Article  PubMed  CAS  Google Scholar 

  20. Urquhart J. Ascertaining how much compliance is enough with outpatient antibiotic regimens. Postgrad Med J 1992; 68(3 Suppl.): S49–S59

    PubMed  Google Scholar 

  21. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6(5): 592–9

    PubMed  CAS  Google Scholar 

  22. White WB, Viadero JJ, Lane TJ, et al. Effects of combination therapy with Captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther 1986; 39: 43–8

    Article  PubMed  CAS  Google Scholar 

  23. Elliott HL, Meredith PA. Nifedipine GITS [letter]. Lancet 1993; 341: 306

    Article  PubMed  CAS  Google Scholar 

  24. Sambol NC, Sheiner LB. Population dose versus response of betaxolol and atenolol: a comparison of potency and variability. Clin Pharmacol Ther 1991; 49: 24–31

    Article  PubMed  CAS  Google Scholar 

  25. Johnson BF, Whelton A, McMahon FG. Betaxolol vs. atenolol in hypertension: a comparison of efficacy, duration of response, and effects of withdrawal [abstract]. Am J Hypertens 1990; 3 (5 Pt II): 121

    Google Scholar 

  26. Zanchetti A, Italian GITS Study Group, Bianchi L, et al. Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertension. J Hypertens 1993; 11(5 Suppl.): S334–5

    CAS  Google Scholar 

  27. Bainbridge AD, Herlihy O, Meredith PA, et al. A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices. Eur J Clin Pharmacol 1993; 45: 425–30

    Article  PubMed  CAS  Google Scholar 

  28. Rudd P, Ahmed S, Zachary V, et al. Issues in patient compliance: the search for therapeutic sufficiency. Cardiology 1992; 80(1 Suppl.): 2–10

    Article  PubMed  Google Scholar 

  29. Rubio A, Cox C, Weintraub M. Prediction of diltiazem plasma concentration curves from limited measurements using compliance data. Clin Pharmacokinet 1992; 22(3): 238–46

    Article  PubMed  CAS  Google Scholar 

  30. Oosterhuis B, Jonkman JH. Advantages and disadvantages of reformulation of older drugs. Clin Pharmacokinet 1993; 25(3): 165–71

    Article  PubMed  CAS  Google Scholar 

  31. Larkin JG, Herrick AL, McGuire GM, et al. Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation. Epilepsia 1991; 32(1): 89–95

    Article  PubMed  CAS  Google Scholar 

  32. Lieberman R, Nelson R. Dose-response and concentration-response relationships: clinical and regulatory perspectives. Ther Drug Monit 1993; 15(6): 498–502

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, Stanford University Medical Center, Stanford, California, USA

    Peter Rudd

  2. Division of Clinical Pharmacology, Stanford University Medical Center, Stanford, California, USA

    Leslie Lenert

Authors
  1. Peter Rudd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie Lenert
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rudd, P., Lenert, L. Pharmacokinetics as an Aid to Optimising Compliance with Medications. Clin. Pharmacokinet. 28, 1–6 (1995). https://doi.org/10.2165/00003088-199528010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199528010-00001

Keywords

Search

Navigation